Endocytosis of advanced glycation end-products in bovine choriocapillaris endothelial cells

Microcirculation

Volumn 16, Issue 7, 2009, Pages 640-655

  Li, Ruomei ^a   McCourt, Peter ^a   Schledzewski, Kai ^b   Goerdt, Sergij ^b   Moldenhauer, Gerhard ^c   Liu, Xipu ^a   Smedsrød, Bård ^a   Sørensen, Karen Kristine ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Bruchs membrane; choriocapillaris; Scavenger endothelial cells; stabilin 1; stabilin 2

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; CELL EXTRACT; POLYCLONAL ANTIBODY; SCAVENGER RECEPTOR; STABILIN 1; STABILIN 2; UNCLASSIFIED DRUG; NERVE CELL ADHESION MOLECULE;

ANIMAL CELL; ARTICLE; BRUCH MEMBRANE; CELL CULTURE; CHORIOCAPILLARIS ENDOTHELIAL CELL; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; COW; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE SECTION; WESTERN BLOTTING; ANIMAL; CAPILLARY; CATTLE; CHOROID; CYTOLOGY; METABOLISM; VASCULAR ENDOTHELIUM; VASCULARIZATION;

BOVINAE;

ANIMALS; BRUCH MEMBRANE; CAPILLARIES; CATTLE; CELL ADHESION MOLECULES, NEURONAL; CELLS, CULTURED; CHOROID; ENDOCYTOSIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; RECEPTORS, SCAVENGER;

EID: 78650771222     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1080/10739680903133185     Document Type: Article

References (53)

1. Araki N, Higashi T, Mori T, Shibayama R, Kawabe Y, Kodama T, et al. (1995). Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 230:408-415.
2. Barile GR, Schmidt AM. (2007). RAGE and its ligands in retinal disease. Curr Mol Med 7:758-765.
3. Baynes JW. (2001). The role of AGEs in aging: causation or correlation. Exp Gerontol 36:1527-1537.
4. Blomhoff R, Eskild W, Berg T. (1984). Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cells. Biochem J 218: 81-86.
5. Brownlee M, Cerami A, Vlassara H. (1988). Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321.
6. de Rijke YB, van Berkel TJ. (1994). Rat liver Kupffer and endothelial cells express different binding proteins for modified low-density lipoproteins. Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low-density lipoproteins. J Biol Chem 269:824-827.
7. Elvevold KH, Nedredal GI, Revhaug A, Smedsrod B. (2004). Scavenger properties of cultivated pig liver endothelial cells. Comp Hepatol 3:4.
8. Falkowski M, Schledzewski K, Hansen B, Goerdt S. (2003). Expression of stabilin-2, a novel fasciclin-like hyaluronan receptor protein, in murine sinusoidal endothelia, avascular tissues, and at solid/liquid interfaces. Histochem Cell Biol 120:361-369.
9. Farboud B, Aotaki-Keen A, Miyata T, Hjelmeland LM, Handa JT. (1999). Development of a polyclonal antibody with broad epitope specificity for advanced glycation end-products and localization of these epitopes in Bruch's membrane of the aging eye. Mol Vis 5:11.
10. Gardiner TA, Archer DB. (1986). Endocytosis in the retinal and choroidal microcirculation. Br J Ophthal-mol 70:361-372.
11. Hammes HP, Hoerauf H, Alt A, Schleicher E, Clausen JT, Bretzel RG, et al. (1999). N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 40:1855-1859.
12. Handa JT, Reiser KM, Matsunaga H, Hjelmeland LM. (1998). The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells. Exp Eye Res 66:411-419.
13. Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, te Koppele JM, et al. (1999). Increase in the advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci 40:775-779.
14. Hansen B, Longati P, Elvevold K, Nedredal GI, Schledzewski K, Olsen R, et al. (2005). Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp Cell Res 303:160-173.
15. Hansen B, Svistounov D, Olsen R, Nagai R, Horiuchi S, Smedsrod B. (2002). Advanced glycation end-products impair the scavenger function of rat hepatic sinusoidal endothelial cells. Diabetologia 45: 1379-1388.
16. Henle T, Miyata T. (2003). Advanced glycation end-products in uremia. Adv Ren Replace Ther 10: 321-331.
17. Hoffmann S, Friedrichs U, Eichler W, Rosenthal A, Wiedemann P. (2002). Advanced glycation end-products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2, and VEGF upregulation in vitro. Graefe's Arch Clin Exp Ophthalmol 240:996-1002.
18. Honjo M, Sawamura T, Hinagata J, Nakamura K, Sanada N, Tanihara H, et al. (2004). Expression of LOX-1, an oxidized low-density lipoprotein receptor, in choroidal neovascularization. Arch Ophthalmol 122:1873-1876.
19. Horiuchi S, Sakamoto Y, Sakai M. (2003). Scavenger receptors for oxidized and glycated proteins. Amino Acids 25:283-292.
20. Irjala H, Elima K, Johansson EL, Merinen M, Kontula K, Alanen K, et al. (2003). The same endothelial receptor controls lymphocyte traffic both in vascular and lymphatic vessels. Eur J Immunol 33:815-824.
21. IshibashiT,MurataT,HangaiM,NagaiR,HoriuchiS, Lopez PF, et al. (1998). Advanced glycation end-products in age-related macular degeneration. Arch Ophthalmol 116:1629-1632.
22. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S. (2002). Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end-products (AGE). FEBS Lett 511:170-174.
23. Kuniyasu A, Ohgami N, Hayashi S, Miyazaki A, Horiuchi S, Nakayama H. (2003). CD36-mediated endocytic uptake of advanced glycation end-products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes. FEBS Lett 537:85-90.
24. Kzhyshkowska J, Mamidi S, Gratchev A, Kremmer E, Schmuttermaier C, Krusell L, et al. (2006). Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is upregulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 107: 3221-3228.
25. Kzhyshkowska J, Workman G, Cardo-Vila M, Arap W, Pasqualini R, Gratchev A, et al. (2006). Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 176:5825-5832.
26. Liu X, Li W. (1993). Isolation, culture, and characterization of bovine choriocapillary endothelial cells. Exp Eye Res 57:37-44.
27. Liu X, Ye X, Yanoff M, Li W. (1997). Extracellular matrix of retinal pigment epithelium regulates choriocapillaris endothelial survival in vitro. Exp Eye Res 65:117-126.
28. McCourt PA, Smedsrod BH, Melkko J, Johansson S. (1999). Characterization of a hyaluronan receptor on rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology 30:1276-1286.
29. Mego JL, Bertini F, McQueen JD. (1967). The use of formaldehyde-treated 131-I-albumin in the study of digestive vacuoles and some properties of these particles from mouse liver. J Cell Biol 32:699-707.
30. Melkko J, Hellevik T, Risteli L, Risteli J, Smedsrod B. (1994). Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells. J Exp Med 179:405-412.
31. Munch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, et al. (1998). Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress, and advanced glycation endproducts. J Neural Transm 105:439-461.
32. Pino RM. (1987). Binding and endocytosis of heparin-gold conjugates by the fenestrated endothelium of the rat choriocapillaris. Cell Tissue Res 250: 257-266.
33. Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, et al. (2002). Stabilin-1 and-2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 362:155-164.
34. Prevo R, Banerji S, Ni J, Jackson DG. (2004). Rapid plasma membrane-endosomal trafficking of the lymph node sinus and high endothelial venule scavenger receptor/homing receptor stabilin-1 (FEEL-1/CLEVER-1). J Biol Chem 279:52580-52592.
35. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. (1997). An endothelial receptor for oxidized low-density lipoprotein. Nature 386:73-77.
36. Scopes RK. (1993). Protein Purification: Principles and Practice, 3rd ed. Springer-Verlag: New York and Heidelberg.
37. Sell DR, Lane MA, Johnson WA, Masoro EJ, Mock OB, Reiser KM, et al. (1996). Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A 93:485-490.
38. Seternes T, Sorensen K, Smedsrod B. (2002). Sca-venger endothelial cells of vertebrates: a nonperipheral leukocyte system for high-capacity elimination of waste macromolecules. Proc Natl Acad Sci U S A 99:7594-7597.
39. Shimokawa I, Higami Y, Horiuchi S, Iwasaki M, Ikeda T. (1998). Advanced glycosylation end pro-ducts in adrenal lipofuscin. J Gerontol A Biol Sci Med Sci 53:B49-B51.
40. Singh R, Barden A, Mori T, Beilin L. (2001). Advanced glycation end-products: a review. Diabetologia 44:129-146.
41. Smedsrod B. (2004). Clearance function of scavenger endothelial cells. Comp Hepatol 3(Suppl 1):S22.
42. Smedsrod B, Kjellen L, Pertoft H. (1985). Endocytosis and degradation of chondroitin sulphate by liver endothelial cells. Biochem J 229:63-71.
43. Smedsrod B, Melkko J, Araki N, Sano H, Horiuchi S. (1997). Advanced glycation end-products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J 322(Pt 2):567-573.
44. Smith SS, Pino RM, Thouron CL. (1989). Binding and transport of transthyretin-gold by the endothe-lium of the rat choriocapillaris. J Histochem Cyto-chem 37:1497-1502.
45. Sorensen KK, Melkko J, Smedsrod B. (1998). Scavenger-receptor-mediated endocytosis in endocardial endothelial cells of Atlantic cod Gadus morhua. J Exp Biol 201:1707-1718.
46. Stitt AW, Bucala R, Vlassara H. (1997). Atherogenesis and advanced glycation: promotion, progression, and prevention. Ann N Y Acad Sci 811:115-127; discussion, 127-129.
47. Takata K, Horiuchi S, Araki N, Shiga M, Saitoh M, Morino Y. (1988). Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scaven-ger receptor for aldehydemodified proteins. J Biol Chem 263:14819-14825.
48. Tamura Y, Adachi H, Osuga J, Ohashi K, Yahagi N, Sekiya M, et al. (2003). FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end-products. J Biol Chem 278:12613-12617.
49. van der Sluijs P, Bootsma HP, Postema B, Moolenaar F, Meijer DK. (1986). Drug targeting to the liver with lactosylated albumins: does the glycoprotein target the drug or is the drug targeting the glycoprotein? Hepatology 6:723-728.
50. Weigel JA, Weigel PH. (2003). Characterization of the recombinant rat 175-kDa hyaluronan receptor for endocytosis (HARE). J Biol Chem 278:42802-42811.
51. Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, et al. (2007). Microvascular permeability in diabetes and insulin resistance. Microcirculation 14:363-373.
52. Yan SF, Ramasamy R, Schmidt AM. (2008). Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4:285-293.
53. Zhou B, Weigel JA, Saxena A, Weigel PH. (2002). Molecular cloning and functional expression of the rat 175-kDa hyaluronan receptor for endocytosis. Mol Biol Cell 13:2853-2868.